Newsfeeds Archive - Spark Newswire

2 minute read

Merck Posts Surprise Quarterly Profit Against An Expected Loss, Oncology And Vaccines Drive Growth

February 1, 11:43 AM

Merck reports fourth quarter 2023 sales of $14.63 billion, a 6% YoY increase, beating estimates. Explore oncology, vaccines, and EPS outlook for 2024.

HARP

2 minute read

Investor Optimism Around Keytruda Drives Merck Stock To Golden Cross Ahead of Earnings

By Surbhi Jain

January 29, 3:05 PM

Merck stock has gained 20% since Nov. 28; a technical signal suggests the rally isn't over. Keytruda approvals also drive optimism.

HARP

3 minute read

Analyst Ratings

Peeling Back The Layers: Exploring Harpoon Therapeutics Through Analyst Insights

By Benzinga Insights

January 16, 5:00 PM

In the latest quarter, 4 analysts provided ratings for Harpoon Therapeutics (NASDAQ:HARP), showcasing a mix of bullish and…

HARP

3 minute read

Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results

By Avi Kapoor

January 8, 3:33 PM

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.35% to 37,596.43 while the NASDAQ rose 1.89% to 14,799.21. The S&P 500 also rose, gaining, 1.11% to 4,749.41.

AMAM

4 minute read

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Avi Kapoor

January 8, 2:36 PM

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.

AMAM

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

January 8, 1:30 PM

Gainers Harpoon Therapeutics (NASDAQ:HARP) stock moved upwards by 112.4% to $22.41 during Monday’s regular session. The market value…

AMAM

3 minute read

Crude Oil Falls Sharply; Ambrx Biopharma Shares Spike Higher

By Avi Kapoor

January 8, 1:22 PM

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining more than 1% on Monday. The Dow traded down 0.19% to 37,396.28 while the NASDAQ rose 1.20% to 14,698.88. The S&P 500 also rose, gaining, 0.55% to 4,722.93.

AMAM

1 minute read

Today Is Cancer-Focused Deals Day: Johnson & Johnson Scoops Up Ambrx Biopharma As Merck Boosts Cancer Portfolio With Harpoon Deal

By Vandana Singh

January 8, 11:18 AM

Monday, Johnson & Johnson (NYSE: JNJ) has agreed to acquire Ambrx Biopharma Inc (NASDAQ: AMAM) in an all-cash merger transaction for a total equity value of approximately $2.0 billion, or $1.9 billi

AMAM

1 minute read

Health Care Company Merck & Co Announces Acquisition of Harpoon Therapeutics

By Benzinga Insights

January 8, 11:10 AM

Merck & Co (NYSE:MRK) has announced an acquisition of Harpoon Therapeutics (NASDAQ:HARP) that is expected to be completed…

HARP

3 minute read

US Stocks Mixed; Nasdaq Jumps Over 100 Points

By Avi Kapoor

January 8, 11:00 AM

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 100 points on Monday. Following the market opening Monday, the Dow traded down 0.45% to 37,296.85 while the NASDAQ rose 0.75% to 14,632.70. The S&P 500 also rose, gaining, 0.26% to 4,709.31.

AMAM